Recommendations by Spine20 The media wanted highlights of National Spin Care Program and Spine 20 2023 draft recommendations. Please find below the highlights of the National Spine Care Program. The draft recommendations of Spine20 2023 are enclosed. Once they are voted upon tomorrow they will be
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24 US FDA approval for API manufacturing plant in Mangalore received Acquisition of land in Hyderabad to support long term growth in research services Syngene International Limited
QOQ Q4 FY 23 vs. Q4 FY 22: The Financials have been prepared in accordance with Ind AS (‘Indian Accounting Standards’): The Revenue from Operations is Rs. 3.40 Cr. in Q4 FY 23 as against Rs. 2.61 Cr. in Q4 FY 22,which is an increase of
